Novo Nordisk A/S Sponsored ADR logo

Novo Nordisk A/S Sponsored ADR (0TDD)

Market Closed
24 Feb, 15:30
LSE LSE
$
38. 82
-0.97
-2.44%
$
- Market Cap
48.26 P/E Ratio
0.56% Div Yield
361,793 Volume
0 Eps
$ 39.79
Previous Close
Day Range
38 39.98
Year Range
38 93.8
Want to track 0TDD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0TDD earnings report is expected in 71 days (6 May 2026)
Name Time Cons. EPS Eps
Novo Nordisk A/S Sponsored ADR logo
0TDD Novo Nordisk A/S Sponsored ADR
6 May 2026 (In 2 months)
4.94
-
Novo Nordisk A/S Sponsored ADR logo
0TDD Novo Nordisk A/S Sponsored ADR
4 Feb 2026
5.9
0.94

0TDD Earnings Reports FAQ

What is the earnings per share (EPS) for 0TDD?

The current EPS is 0.

What is the company's earnings growth rate?

Novo Nordisk A/S Sponsored ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-05-06, based on the 0TDD's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 0.9419 per share, reported on 2026-02-04. For dividend history, visit the 0TDD Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 41.21, calculated based on the most recent stock price of $38.82.